English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 134 Help

Selected(0)Clear Items/Page:    Sort:
Identify critical genes of breast cancer and corresponding leading natural product compounds of potential therapeutic targets Journal article
Fan, Xiaokai, Xin, Le, Yu, Xuan, Liu, Maoxuan, Shim, Joong Sup, Yang, Gui, Chen, Liang. Identify critical genes of breast cancer and corresponding leading natural product compounds of potential therapeutic targets[J]. Molecular Diversity, 2024.
Authors:  Fan, Xiaokai;  Xin, Le;  Yu, Xuan;  Liu, Maoxuan;  Shim, Joong Sup; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:3.9/3.5 | Submit date：2024/12/26
Breast Cancer  Hub Genes  Leading Compounds  Targeted Therapy  
Targeting hexokinase 2 to enhance anticancer efficacy of trichosanthin in HeLa and SCC25 cell models Journal article
Zhou, Yan, Ran, Maoxin, Shan, Wenying, Wang, Kaifang, Sha, Ou, Tam, Kin Yip. Targeting hexokinase 2 to enhance anticancer efficacy of trichosanthin in HeLa and SCC25 cell models[J]. ADMET and DMPK, 2024, 12(6), 821-841.
Authors:  Zhou, Yan;  Ran, Maoxin;  Shan, Wenying;  Wang, Kaifang;  Sha, Ou; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:3.4/2.8 | Submit date：2025/01/13
Ribosome-inactivating Protein  Glycolysis  Drug Combination  Synergistic Effect  Cancer Therapy  
A small molecule cryptotanshinone induces non-enzymatic NQO1-dependent necrosis in cancer cells through the JNK1/2/Iron/PARP/calcium pathway Journal article
Hou, Ying, Zhong, Bingling, Zhao, Lin, Wang, Heng, Zhu, Yanyan, Wang, Xianzhe, Zheng, Haoyi, Yu, Jie, Liu, Guokai, Wang, Xin, Martin-Garcia, Jose M., Chen, Xiuping. A small molecule cryptotanshinone induces non-enzymatic NQO1-dependent necrosis in cancer cells through the JNK1/2/Iron/PARP/calcium pathway[J]. Acta Pharmaceutica Sinica B, 2024.
Authors:  Hou, Ying;  Zhong, Bingling;  Zhao, Lin;  Wang, Heng;  Zhu, Yanyan; et al.
Favorite | TC[Scopus]:0  IF:14.7/14.1 | Submit date：2025/01/22
Nqo1  Cryptotanshinone  Iron  Ferroptosis  Nad++++ Depletion  Calcium  Targeted Therapy  Cancer  
Recent Advances in Silica-Based Nanomaterials for Enhanced Tumor Imaging and Therapy Journal article
Zhang, Junjie, Liu, Zilu, Zhang, Zhijing, Yang, Hui, Wang, Hui, Yang, Zhenlu, Xu, Yunjian, Li, Shengke, Yang, Dongliang. Recent Advances in Silica-Based Nanomaterials for Enhanced Tumor Imaging and Therapy[J]. ACS Applied Bio Materials, 2024, 7(11), 7133-7169.
Authors:  Zhang, Junjie;  Liu, Zilu;  Zhang, Zhijing;  Yang, Hui;  Wang, Hui; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:4.6/4.4 | Submit date：2024/12/26
biocompatibility  cancer therapy  drug delivery  silica-based nanomaterials  tumor imaging  
Recent Advances in Silica-Based Nanomaterials for Enhanced Tumor Imaging and Therapy Review article
2024
Authors:  Zhang, Junjie;  Liu, Zilu;  Zhang, Zhijing;  Yang, Hui;  Wang, Hui; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:4.6/4.4 | Submit date：2024/12/05
Biocompatibility  Cancer Therapy  Drug Delivery  Silica-based Nanomaterials  Tumor Imaging  
Graphene-Metal Nanocrystal Hybrid Materials for Bioapplications Review article
2024
Authors:  Cao, Xiaoxu;  Li, Shengkai;  Wang, Shen;  Guo, Rongshen;  Dong, Qian; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:8.3/8.7 | Submit date：2024/11/05
Antibacterial  Bioimaging  Biosensing  Cancer Therapy  Graphene-metal Nanocrystal Hybrid Materials  
Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products Journal article
Zhang, Le Le, Zhang, Du Juan, Shi, Jia Xin, Huang, Mu Yang, Yu, Jia Mei, Chen, Xu Jia, Wei, Xiao, Zou, Liang, Lu, Jin Jian. Immunogenic cell death inducers for cancer therapy: An emerging focus on natural products[J]. Phytomedicine, 2024, 132, 155828.
Authors:  Zhang, Le Le;  Zhang, Du Juan;  Shi, Jia Xin;  Huang, Mu Yang;  Yu, Jia Mei; et al.
Favorite | TC[WOS]:2 TC[Scopus]:3  IF:6.7/6.2 | Submit date：2024/07/04
Immunogenic Cell Death  Regulated Cell Death  Natural Products  Cancer Therapy  Tumor Immune Microenvironment  
Unrestricted molecular motions enable mild photothermy for recurrence-resistant FLASH antitumor radiotherapy Journal article
Shen, Hanchen, Wang, Hongbin, Mo, Jianlan, Zhang, Jianyu, Xu, Changhuo, Sun, Feiyi, Ou, Xinwen, Zhu, Xinyan, Du, Lidong, Ju, Huaqiang, Ye, Ruquan, Shi, Guangfu, Kwok, Ryan T.K., Lam, Jacky W.Y., Sun, Jianwei, Zhang, Tianfu, Ning, Shipeng, Tang, Ben Zhong. Unrestricted molecular motions enable mild photothermy for recurrence-resistant FLASH antitumor radiotherapy[J]. Bioactive Materials, 2024, 37, 299-312.
Authors:  Shen, Hanchen;  Wang, Hongbin;  Mo, Jianlan;  Zhang, Jianyu;  Xu, Changhuo; et al.
Favorite | TC[WOS]:6 TC[Scopus]:6  IF:18.0/18.2 | Submit date：2024/05/16
Flash Radiotherapy  Cancer Recurrence  Mild Photothermal Therapy  Aggregation-induced Emission  Molecular Motion  
Dissecting the pleiotropic roles of reactive oxygen species (ROS) in lung cancer: From carcinogenesis toward therapy Journal article
Hou, Ying, Wang, Heng, Wu, Jiarui, Guo, Hongwei, Chen, Xiuping. Dissecting the pleiotropic roles of reactive oxygen species (ROS) in lung cancer: From carcinogenesis toward therapy[J]. Medicinal Research Reviews, 2024, 44(4), 1566-1595.
Authors:  Hou, Ying;  Wang, Heng;  Wu, Jiarui;  Guo, Hongwei;  Chen, Xiuping
Favorite | TC[WOS]:9 TC[Scopus]:9  IF:10.9/12.9 | Submit date：2024/05/16
Cancer Therapy  Carcinogenesis  Lung Cancer  Ros  
Blockage of Autophagy for Cancer Therapy: A Comprehensive Review Review article
2024
Authors:  Hassan, Ahmed Mostafa Ibrahim Abdelrahman;  Zhao, Yuxin;  Chen, Xiuping;  He, Chengwei
Favorite | TC[WOS]:8 TC[Scopus]:8 | Submit date：2024/10/10
Autophagy Inhibitors  Cancer Therapy  Clinical Trials